AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimiwave M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

UHC Life Sciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimiwave M 1mg/500mg Tablet SR

Diabetic patients utilizing the extended-release Glimiwave M 1mg/500mg tablet, an antidiabetic medication combining two active components, should adhere to their physician's prescribed dosage and regimen. This dual-action formulation manages blood glucose levels in adult type 2 diabetics. Consistent daily administration, ideally with meals, maximizes efficacy. Dosage adjustments may occur based on blood sugar monitoring. Discontinuing Glimiwave M without medical consultation risks elevated blood sugar, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and limb loss. A comprehensive diabetes management plan necessitates this medication alongside dietary modifications, physical activity, and weight management as recommended by your healthcare provider. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods, fruit juice) is crucial for managing hypoglycemic episodes. Alcohol consumption should be minimized due to its potential to exacerbate low blood sugar. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or significant hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose checks, along with potential blood tests to monitor hematological parameters and liver function, are essential for safe and effective management.

Primary Ingredients of Glimiwave M 1mg/500mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Glimiwave M 1mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glimiwave M 1mg/500mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimiwave M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimiwave M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimiwave M 1mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glimiwave M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

How Glimiwave M 1mg/500mg Tablet SR works:

Glimiwave M SR tablets (1mg/500mg) combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimiwave M 1mg/500mg Tablet SR with alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimiwave M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimiwave M tablets (1mg/500mg) are contraindicated for use while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimiwave M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimiwave M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, it's contraindicated in those with severe liver disease.

What if you forget to take Glimiwave M 1mg/500mg Tablet SR :

Should you forget a Glimiwave M 1mg/500mg SR tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimiwave M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Glimiwave M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimiwave M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimiwave M 1mg/500mg Tablet SR and seek immediate medical attention.
Glimiwave M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimiwave M 1mg/500mg SR tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimiwave M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glimiwave M 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimiwave M 1mg/500mg SR tablets with alcohol is unsafe. Alcohol can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimiwave M 1mg/500mg Tab...
56
MRP 65
13% off